Telmisartan and hydrochlorothiazide
Telmisartan and Hydrochlorothiazide is a prescription oral tablet combining two medications: telmisartan, an angiotensin II receptor blocker, and hydrochlorothiazide, a thiazide diuretic. It's used to treat high blood pressure (hypertension) by helping relax blood vessels and reduce fluid retention. Available in strengths like 40/12.5 mg and 80/12.5 mg or 80/25 mg tablets, manufactured by Solco Healthcare LLC under ANDA209028. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Telmisartan and Hydrochlorothiazide is a prescription oral tablet combining two medications: telmisartan, an angiotensin II receptor blocker, and hydrochlorothiazide, a thiazide diuretic. It's used to treat high blood pressure (hypertension) by helping relax blood vessels and reduce fluid retention. Available in strengths like 40/12.5 mg and 80/12.5 mg or 80/25 mg tablets, manufactured by Solco Healthcare LLC under ANDA209028. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Telmisartan and hydrochlorothiazide", "mediaType": "text/html", "description": " Access the FDA dataset for Telmisartan and hydrochlorothiazide — ANDA 202544 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202544" } ] |
| identifier | ANDA202544 |
| issued | 2016-09-16 |
| keyword |
[ "drug-information", "drug-manufacturers", "drug-safety", "prescription-drugs", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Telmisartan and hydrochlorothiazide |
